Tamoxifen News and Research

RSS
Tamoxifen is a drug used to treat certain types of breast cancer in women and men. It is also used to prevent breast cancer in women who have had ductal carcinoma in situ (abnormal cells in the ducts of the breast) and in women who are at a high risk of developing breast cancer. Tamoxifen is also being studied in the treatment of other types of cancer. It blocks the effects of the hormone estrogen in the breast. Tamoxifen is a type of antiestrogen. Also called tamoxifen citrate.
Researchers identify molecule to fight myotubular myopathy

Researchers identify molecule to fight myotubular myopathy

New model of FSHD could be useful to study effectiveness of experimental therapeutics

New model of FSHD could be useful to study effectiveness of experimental therapeutics

Radiation therapy can lower risk of breast cancer recurrence in patients with ‘good risk’ DCIS

Radiation therapy can lower risk of breast cancer recurrence in patients with ‘good risk’ DCIS

Drugs approved for breast cancer treatment are effective and well tolerated in men

Drugs approved for breast cancer treatment are effective and well tolerated in men

Phase III trial reports positive results with HDAC inhibitor in advanced breast cancer patients

Phase III trial reports positive results with HDAC inhibitor in advanced breast cancer patients

Zoledronic acid increases disease-free survival in premenopausal women with HR+ early breast cancer

Zoledronic acid increases disease-free survival in premenopausal women with HR+ early breast cancer

High rate of non-adherence to hormonal therapy found among premenopausal early breast cancer patients

High rate of non-adherence to hormonal therapy found among premenopausal early breast cancer patients

Columbia University announces winners of 2018 Louisa Gross Horwitz Prize

Columbia University announces winners of 2018 Louisa Gross Horwitz Prize

Women with high levels of anti-Müllerian hormone more likely to develop breast cancer

Women with high levels of anti-Müllerian hormone more likely to develop breast cancer

Researchers untangle mysteries of 'evil' protein in ER-positive breast cancer

Researchers untangle mysteries of 'evil' protein in ER-positive breast cancer

Lumpectomy plus radiation associated with reduced risk of breast cancer death, study finds

Lumpectomy plus radiation associated with reduced risk of breast cancer death, study finds

Breast cancer studies not taking sufficient account of race, socioeconomic factors

Breast cancer studies not taking sufficient account of race, socioeconomic factors

Study: Long-term estrogen therapy alters microbial composition and activity in the gut

Study: Long-term estrogen therapy alters microbial composition and activity in the gut

Topical gel may lower breast cancer risk in women with dense breast tissue

Topical gel may lower breast cancer risk in women with dense breast tissue

Biotheranostics presents key data for CancerTYPE ID and Breast Cancer Index at ASCO 2018

Biotheranostics presents key data for CancerTYPE ID and Breast Cancer Index at ASCO 2018

Loved one's experience has impact on woman's cancer prevention decisions

Loved one's experience has impact on woman's cancer prevention decisions

New clinical practice guideline for using CYP2D6 genotype to guide tamoxifen therapy

New clinical practice guideline for using CYP2D6 genotype to guide tamoxifen therapy

Mount Sinai researchers identify new therapeutic target for ER+ breast cancer

Mount Sinai researchers identify new therapeutic target for ER+ breast cancer

Women with ER-positive breast cancer face disease recurrence risk years after treatment ends

Women with ER-positive breast cancer face disease recurrence risk years after treatment ends

Gut bacteria composition could predict toxicity of chemotherapy drugs in cancer patients

Gut bacteria composition could predict toxicity of chemotherapy drugs in cancer patients